Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 21st Annual Congress of the European Respiratory Society

Early Diagnosis Key to Improving Long-term Outcomes in Patients with Pulmonary Arterial Hypertension

Amsterdam, The Netherlands / September 24-28, 2011

Amsterdam - The benefits of treating pulmonary arterial hypertension (PAH) at an early stage of the disease have been clearly demonstrated and are supported by current treatment guidelines. PAH patients in NYHA/WHO functional class (FC) II...

PRIORITY PRESS - 22nd Annual Meeting of the North American Menopause Society

Rethinking Prophylaxis of Post-menopausal Risks

Washington, D.C. / September 21-24, 2011

Washington, D.C. - A more rational approach to hormone replacement therapy, particularly the use of estrogens to maintain function in estrogen-dependent tissues, such as the bone and structures of the urogenital tract, is being driven by...

PRIORITY PRESS - 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

Treating Complicated MRSA in Hospitalized Patients: Comparing IDSA Guidelines with New Data

Chicago, Illinois / September 17-20, 2011

Chicago - In new evidence-based Infectious Diseases Society of America (IDSA) guidelines for the management of methicillin-resistant Staphylococcus aureus (MRSA), multiple antibiotic regimens received an A-I designation for one or more of...

PRIORITY PRESS - 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

Therapeutic Drug Monitoring Emphasized in the Context of Life-threatening Infections

Chicago, Illinois / September 17-20, 2011

Chicago - Prophylactic and empirical therapy with first-line antifungal agents is becoming increasingly dependent on therapeutic drug monitoring (TDM). The efficacy relationship between drug exposure and cure, particularly in the context of...

PRIORITY PRESS - 47th Annual Meeting of the European Association for the Study of Diabetes (EASD)

New Targets for Glycemic Control in the Treatment of Type 2 Diabetes Mellitus

Lisbon, Portugal / September 12-16, 2011

Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec According to Dr. Peter Rossing, Chief Physician and Head of Research, Steno Diabetes Center, Gentofte, Denmark, in type 2 diabetes, progressive ß-cell...

PRIORITY PRESS - 17th International Meeting of the European Society of Gynecological Oncology

Emerging Therapies for Advanced Ovarian Cancer

Milan, Italy / September 11-14, 2011

Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec Generally, platinum sensitivity refers to a platinum-free interval (PFI) >12 months. However, that definition does not address a substantial proportion of patients...

PRIORITY PRESS - 23rd Annual National Canadian Association of Nurses in Oncology Conference

Management of Catheter Occlusion and Home Intravenous Chemotherapy: Increasing Patient Safety and Comfort

Halifax, Nova Scotia / September 11-14, 2011

Halifax - It is estimated that 25% of all catheters become occluded, the majority from thrombus formation. Early recognition of a partial or complete occlusion is critical as without prompt initiation of fibrinolytic therapy, patients and...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 15th Congress of the European Society for Organ Transplantation

Improving Long-term Renal Graft Survival

Glasgow, UK / September 4-7, 2011

Reviewed and edited by: Jeffrey S. Zaltzman, MD, FRCPC Director, Renal Transplant, St. Michael’s Hospital, Associate Professor of Medicine, Division of Nephrology, University of Toronto, Toronto, Ontario Causes of Graft...

ABSTRACTS in PERSPECTIVE - based on presentations from the 12th Annual European Congress of Rheumatology (EULAR)

Complete Remission as a Therapeutic Goal in Rheumatoid Arthritis: Accelerating Research with Biologics and Through New Inflammatory Pathways

London, UK / May 25-28, 2011

EDITORIAL OVERVIEW: Alfred A. Cividino, MD, FRCPC Clinical Professor of Medicine, Division of Rheumatology, McMaster University, Hamilton, Ontario A gents highly targeted at key molecular steps in the inflammatory process have...

PAGE 31 OF 124   ... 31 32 33 34 35 36 37 38 39 40 ...